Invitation

Actelion to discuss first quarter 2016 financial results

Actelion Pharmaceuticals Ltd / Invitation: Actelion to discuss first quarter 2016 financial results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Dear member of the investment community,

Actelion Ltd will announce its first quarter 2016 financial results on Thursday, 21 April 2016, at 07:00 hrs CEST.
An investor conference call and webcast will be held at 15:00 hrs CEST to discuss the results.

To support your preparations, consensus estimates can be found under www.actelion.com/consensus-estimate

Date/Time:

21 April 2016	15:00 hrs - 16:00 hrs	Basel
	14:00 hrs - 15:00 hrs	London
	09:00 hrs - 10:00 hrs	New York

Conference Call Connect #:
Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.

Dial:	Europe:	[phone]
	UK:	[phone]
	US:	[phone]

Participant's mode:
Listen-Only with possibility to open individual lines during Q&A session. Participants will be asked for their name and company.

Webcast Access:
Webcast participants should go to the Actelion website http://www.actelion.com 10-15 minutes before the conference is due to start.

Participant's mode: Listen-Only

Webcast Replay:

The archived Investor Webcast will be available for replay through http://www.actelion.com/  approximately 60 minutes after the call has ended.

Actelion Pharmaceuticals Ltd

Investor Relations

Gewerbestrasse 16 | CH-4123 Allschwil | Switzerland | phone [phone] | fax [phone]

[e-mail] | www.actelion.com

 

Invitation PDF

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire

HUG#2003599

--- End of Message ---

Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland

ISIN: CH0010532478;